Released on 2023-07-21

PRECISESADS: Cross Sectional Study & Inception Cohort data

Accession number
ELU-2-E592B0-1
Description
Aggregated data containing genomics variant array, RNASeq, and methylation array from cross-sectional and inception cohorts. Dataset provided as anonymized.

Version
V1.0
Created on
2017-01-19
Updated on
2017-09-05
Experiment types
clinical data RNASeq Metabolomics Methylation array Other Genomics variant array
Type of Samples Collected
Urine Serum Plasma Blood
Number of Samples Collected
-
Diseases in samples
systemic autoimmune diseases

info Constrained permissions

Use Restriction Remarks Category (GA4GH)
Use is limited to research in the field of systemic auto immune diseases (SADS) Limited scope of research. Is data consented to be used only in specific research/disease areas? E.g. use only in Biomedical Research or Parkinson's Research etc. Disease-specific Research and Clinical Care. (DS)
Use is limited to non-commercial scientific research project and publication purposes. Such non-commercial use by a commercial entity is permitted. Not-for-profit Use Only (NPU)

hardware Obligations

Use Restriction Remarks Category (GA4GH)
Acknowledgement is required: This work has received support from the EU/EFPIA Innovative Medicines Initiative, Joint Undertaking PRECISESADS grant no° 115565. Where reasonable consider if partners of PRECISESADS may be co-authors. Publication requirements Are there any requirements in case of publications based on the DATA? E.g. papers should cite the cohort study. Publication Required (PUB)
The Sustainability Committee established by the Data Providers must be informed of any publication using PRECISESADS data. As a result, the user institution must inform ELIXIR-LU of any publication concerning these data, regardless of the frequency Publication requirements Are there any requirements in case of publications based on the DATA? E.g. papers should cite the cohort study.E.g. papers should cite the cohort study. Publication Required (PUB)
Acknowledgement of the ELIXIR Luxembourg by following statement is required in all publications resulting from any analyses of the data: "This work was supported by ELIXIR Luxembourg" Acknowledgement of the ELIXIR Luxembourg is required in all publications based on the data provided. Publication Required (PUB)